MoneyWorks4Me

Eris Lifesciences to acquire full ownership in KINEDEX

08 Apr 2019 Evaluate

Eris Lifesciences has executed a share purchase agreement with Rajesh Dhuria (one of the founders & promoters of KINEDEX) with the intent to have full ownership and control of the said subsidiary (KINEDEX) and to make KINEDEX a wholly-owned subsidiary i.e. by way of purchase of 32,507 equity shares of face value of Rs 10 each (equivalent to around 17.81%).

Prior to this transaction, the Company held around 82.19% shareholding in KINEDEX. Post completion of this transaction, the total holding of the Company shall stand at 100%.

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris Lifesciences Share Price

1298.10 0.15 (0.01%)
01-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1930.45
Dr. Reddys Labs. 1171.00
Cipla 1418.00
Lupin 2150.00
Zydus Lifesciences 1164.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: